These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An efficient and practical method for solid-phase synthesis of tripeptide-bearing glycopeptide antibiotics: combinatorial parallel synthesis of carboxamide derivatives of chloroorienticin B. Yasukata T; Shindo H; Yoshida O; Sumino Y; Munekage T; Narukawa Y; Nishitani Y Bioorg Med Chem Lett; 2002 Nov; 12(21):3033-6. PubMed ID: 12372495 [TBL] [Abstract][Full Text] [Related]
3. Antibiotic activities and affinities for bacterial cell wall analogue of N-demethylvancomycin and its derivatives. Yan H; Qi D; Cheng X; Song Z; Li W; He B J Antibiot (Tokyo); 1998 Aug; 51(8):750-6. PubMed ID: 9766467 [TBL] [Abstract][Full Text] [Related]
11. Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus. Aucken HM; Warner M; Ganner M; Johnson AP; Richardson JF; Cookson BD; Livermore DM J Antimicrob Chemother; 2000 Oct; 46(4):639-40. PubMed ID: 11020266 [No Abstract] [Full Text] [Related]
12. Design and synthesis of new vancomycin derivatives. Gu W; Chen B; Ge M Bioorg Med Chem Lett; 2014 May; 24(10):2305-8. PubMed ID: 24751442 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of spontaneous resistance to glycopeptide antibiotics in staphylococcal populations. Biavasco F; Montanari MP; Facinelli B; Varaldo PE J Chemother; 1989 Jul; 1(4 Suppl):389-90. PubMed ID: 16312453 [No Abstract] [Full Text] [Related]
14. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics. Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121 [TBL] [Abstract][Full Text] [Related]
15. A stepwise dechlorination/cross-coupling strategy to diversify the vancomycin 'in-chloride'. Wadzinski TJ; Gea KD; Miller SJ Bioorg Med Chem Lett; 2016 Feb; 26(3):1025-1028. PubMed ID: 26725950 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel hamamelitannin analogues as potentiators for vancomycin in the treatment of biofilm related Staphylococcus aureus infections. Vermote A; Brackman G; Risseeuw MDP; Coenye T; Van Calenbergh S Bioorg Med Chem; 2016 Oct; 24(19):4563-4575. PubMed ID: 27507109 [TBL] [Abstract][Full Text] [Related]
17. Glycopeptide resistance amongst Staphylococcus spp. van den Braak N; van Belkum A; te Witt R; Verbrugh HA; Endtz HP J Antimicrob Chemother; 1998 Nov; 42(5):673-5. PubMed ID: 9848458 [No Abstract] [Full Text] [Related]
18. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974 [TBL] [Abstract][Full Text] [Related]